Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1/2 3Phase 1 3Phase 3 2Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 57Lymphoma, Large B-Cell, Diffuse 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Follicular 33Leukemia 30Lymphoma, Non-Hodgkin 28Burkitt Lymphoma 19Hodgkin Disease 18Neuroblastoma 13Lymphoma, Large-Cell, Immunoblastic 12Central Nervous System Neoplasms 12Sarcoma 10Multiple Myeloma 10Lymphoma, Mantle-Cell 10Rhabdomyosarcoma 9Wilms Tumor 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, B-Cell, Marginal Zone 7Oligodendroglioma 6Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasms, Plasma Cell 5Neoplasms 5Malignant mesenchymal tumor 5Leukemia, Lymphocytic, Chronic, B-Cell 5Brain Neoplasms 5Astrocytoma 5Retinoblastoma 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Vincristine 2Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Busulfan 2treosulfan 1ganitumab 1etoposide phosphate 1Zoledronic Acid 1Triptorelin Pamoate 1Temozolomide 1Radiosurgery 1Radiation 1Melphalan 1Irinotecan 1FANG vaccine 1Diphosphonates 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Ewing × Vincristine × Clear all
NCT02306161 2026-06-03

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

NCT02063022 2022-09-19

EW-1

Italian Sarcoma Group

Phase 3 Completed
278 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡